Patent details

EP3953334 Title: NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10- {4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)- PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15 -(METHENO)PYRAZOLO [4,3-B] [1,7] DIAZACYCLOTETRADECIN-5(6H)-ONE

Basic Information

Publication number:
EP3953334
PCT Application Number:
US2020027655
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP207213745
PCT Publication Number:
WO2020210613
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10- {4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)- PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15 -(METHENO)PYRAZOLO [4,3-B] [1,7] DIAZACYCLOTETRADECIN-5(6H)-ONE
French Title of Invention:
NOUVELLES OPTIONS SYNTHÉTIQUES POUR LA FABRICATION DE (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL) PHÉNYL]-6-OXO-1(6H)-PYRIMIDINYL}1-(DIFLUOROMÉTHYL)-6-MÉTHYL-1,4,7,8,9,10-HEXAHYDRO-11,15- (METHENO)PYRAZOLO [4,3-B] [1,7] DIAZACYCLOTÉTRADECIN-5 (6H)-ONE
German Title of Invention:
NEUARTIGE SYNTHETISCHE MÖGLICHKEITEN ZUR HERSTELLUNG VON (6R,10S)-10-{4-[5-CHLOR-2-(4-CHLOR-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)- PYRIMIDINYL}-1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO [4,3-B] [1,7] DIAZACYCLOTETRADECIN-5(6H)-ON
SPC Number:

Dates

Filing date:
10/04/2020
Grant date:
22/11/2023
EP Publication Date:
16/02/2022
PCT Publication Date:
15/10/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/11/2023
EP B1 Publication Date:
22/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/04/2024
Expiration date:
10/04/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/11/2023
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Inventor

1

Name:
BROGGINI, Diego Fernando Domenico
Address:
Switzerland (CH)

2

Name:
FAN, Yu
Address:
United States (US)

3

Name:
WEI, Carolyn S.
Address:
United States (US)

4

Name:
CAO, Duy Chi Trung
Address:
Switzerland (CH)

5

Name:
SIMMONS, Eric M.
Address:
United States (US)

6

Name:
ZHENG, Bin
Address:
United States (US)

7

Name:
BEN HAIM, Cyril
Address:
Belgium (BE)

8

Name:
KOLOTUCHIN, Sergei
Address:
United States (US)

9

Name:
CUNIERE, Nicolas
Address:
United States (US)

10

Name:
MUKHERJEE, Subha
Address:
United States (US)

11

Name:
CHERNICHENKO, Kostiantyn
Address:
Belgium (BE)

12

Name:
LEMAIRE, Sébastien François Emmanuel
Address:
Belgium (BE)

13

Name:
SINGH, Amarjit
Address:
United States (US)

14

Name:
XIAO, Yi
Address:
United States (US)

15

Name:
YUAN, Changxia
Address:
United States (US)

16

Name:
WAGSCHAL, Simon Albert
Address:
Switzerland (CH)

Priority

Priority Number:
201962832614 P
Priority Date:
11/04/2019
Priority Country:
United States (US)

Classification

IPC classification:
C07D 213/61; C07D 401/04; C07D 471/18;

Publication

European Patent Bulletin

Issue number:
202347
Publication date:
22/11/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages